Tech Company Financing Transactions
Aitrics Funding Round
Aitrics, based in Seoul, secured $23.7 million from KB Securities, Mirae Asset Capital and Mirae Asset Venture Investment.
Transaction Overview
Company Name
Announced On
12/1/2025
Transaction Type
Venture Equity
Amount
$23,700,000
Round
Series C
Investors
Proceeds Purpose
The company will use the funds to enhance flagship products AITRICS-VC and V.Doc Pro AI, support research and development (R&D) for new pipelines, and expand overseas operations in Asia and North America.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
13F, 218, Teheran-ro, Gangnam-gu
Seoul, Undisclosed
South Korea
Seoul, Undisclosed
South Korea
Phone
Website
Email Address
Overview
AITRICS provides artificial intelligence-based medical services with world-class AI technology and clinical problem-solving capabilities. AITRICS brings risk prevention to a focus, if the causes are identified beforehand. AITRICS-VC, which is our product, is a medical software that has been developed to monitor the patient's statement in real-time to predict emergencies at the early stage.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
KwangJoon Kim
Chief Technical Officer
Eunho Yang
Browse more venture capital transactions:
Prev: 12/1/2025: Sokin venture capital transaction
Next: 12/2/2025: Axoltis Pharma venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs